Tscan therapeutics named the highest-placed midsize biotechnology company in the top places to work for 2022 by the boston globe

Waltham, mass., dec. 01, 2022 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced it has been named one of the top places to work in massachusetts in the 15th annual employee-based survey project from the boston globe. the top places to work 2022 was published online at globe.com/topplaces and will appear in the globe magazine on sunday, december 4, 2022. tscan ranks as the top midsize biotechnology company, and 8th out of the top fifty midsize companies overall in the top places to work in massachusetts in the 15th annual employee-based survey project.
TCRX Ratings Summary
TCRX Quant Ranking